Pregabalin
Pregabalin is a prescription medicine used to treat nerve pain, fibromyalgia, and partial-onset seizures across several brand and generic products.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 233 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Pregabalin: Patient Information Guide
A plain-language walkthrough of Pregabalin — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Pregabalin is used to treat nerve pain, fibromyalgia, and seizures — but which conditions it's approved for depends on the specific product.
- Neuropathic pain from diabetic peripheral neuropathy (nerve pain from diabetes): All products — Lyrica capsules, Lyrica oral solution, Lyrica CR, pregabalin capsules, pregabalin oral solution, and pregabalin extended-release tablets
- Postherpetic neuralgia (nerve pain after shingles): All products listed above
- Fibromyalgia: Lyrica capsules, Lyrica oral solution, pregabalin capsules, and pregabalin oral solution only — NOT Lyrica CR or pregabalin extended-release tablets
- Neuropathic pain from spinal cord injury: Lyrica capsules, Lyrica oral solution, pregabalin capsules, and pregabalin oral solution only
- Add-on therapy for partial-onset seizures (patients 1 month and older): Lyrica capsules and Lyrica oral solution only
- Add-on therapy for partial-onset seizures (patients 17 years and older): Pregabalin capsules and pregabalin oral solution only
- Not approved for fibromyalgia or seizures: Lyrica CR and pregabalin extended-release tablets — effectiveness has not been established for these uses
⚙️How it works▾
Pregabalin binds tightly to a specific protein on voltage-gated calcium channels in the brain and spinal cord called the alpha-2-delta subunit. By doing this, it appears to reduce the release of pain-signaling chemicals (neurotransmitters) from overactive nerve cells, helping to quiet down the pain signals traveling through the nervous system. It may also work through pain-regulating pathways that run from the brainstem down into the spinal cord. Though it looks chemically similar to GABA — the brain's main calming chemical — pregabalin does not act directly on GABA receptors and works through a different mechanism entirely.
💊How it's taken▾
How you take pregabalin depends on which product you're prescribed. Capsules and oral solution are taken two or three times daily and can be taken with or without food. Lyrica CR and pregabalin extended-release tablets are taken once daily after an evening meal and must be swallowed whole — never split, crushed, or chewed. If you miss a dose of an extended-release tablet in the evening, you can take it before bed with a snack; if you miss the bedtime dose, take it after a morning meal.
- Never stop pregabalin suddenly — always taper the dose slowly over at least one week
- Your dose will be adjusted if you have kidney problems, since pregabalin is cleared through the kidneys
- Older adults may need lower doses due to age-related changes in kidney function
🤒Side effects — in detail▾
The most common side effects of pregabalin tend to be dose-related and usually start shortly after beginning treatment.
- Dizziness — very common; was the most frequent reason people stopped the drug in clinical trials
- Drowsiness (somnolence) — also very common, especially at higher doses
- Dry mouth
- Swelling in the hands, feet, or legs (peripheral edema)
- Weight gain
- Blurred or double vision — usually resolves with continued use
- Trouble concentrating or thinking clearly
- Unsteady walking or poor coordination (ataxia)
Seek medical attention right away for serious reactions: throat or face swelling (angioedema), hives or severe skin reactions, new or worsening depression or suicidal thoughts, or any signs of slow or labored breathing.
⚠️Warnings & precautions▾
- Breathing problems (respiratory depression): Pregabalin can cause serious or even fatal slowing of breathing, especially when combined with opioids or other CNS depressants. This risk also exists — though less commonly — without those combinations.
- Suicidal thoughts and behavior: Like all anti-seizure medicines, pregabalin increases the risk of suicidal thinking. This risk applies to anyone taking it, regardless of the reason. Watch for mood changes, worsening depression, or unusual behavior and report them to your doctor immediately.
- Angioedema and severe allergic reactions: Swelling of the face, mouth, throat, or neck can be life-threatening. Stop the medicine and get emergency help right away if this happens.
- Do not stop suddenly: Abrupt discontinuation can cause withdrawal symptoms (insomnia, nausea, headache, anxiety) and increases seizure risk in people with seizure disorders. Always taper slowly.
- Dizziness and drowsiness: These are common and can impair your ability to drive or use machinery — be cautious until you know how pregabalin affects you.
- Swelling and weight gain: Pregabalin can cause fluid retention and weight gain. This is more pronounced when combined with thiazolidinedione diabetes drugs (such as pioglitazone). Use caution in people with heart failure.
🔀What it interacts with▾
Pregabalin itself is unlikely to affect how other drugs are processed by the liver, but it can add to the effects of drugs that slow the brain or nervous system.
- Opioids (e.g., oxycodone): Increases risk of serious respiratory depression and sedation — both prescribers need to be aware if you take both
- Benzodiazepines and other CNS depressants (e.g., lorazepam): Worsens thinking and motor coordination when combined
- Alcohol: Adds to sedation and impairs cognitive and physical functioning
- Thiazolidinedione diabetes drugs (e.g., pioglitazone, rosiglitazone): Higher rates of swelling and weight gain when combined with pregabalin
- ACE inhibitors: May increase the risk of angioedema (throat/face swelling) in people already on these blood pressure medicines
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Allergy to pregabalin: Do not take pregabalin if you've had a hypersensitivity reaction to it before — this is a contraindication
- Kidney problems: Dose must be reduced in anyone with impaired kidney function, since pregabalin is cleared almost entirely by the kidneys
- Older adults: Kidney function naturally declines with age, so dose adjustment may be needed
- Pregnancy: Observational data suggest a possible small increase in the risk of birth defects; animal studies showed developmental toxicity at high doses. Discuss risks and benefits carefully with your doctor. A pregnancy registry is available (call 1-888-233-2334).
- Breastfeeding: Pregabalin passes into breast milk. Due to a potential risk to the infant, breastfeeding is not recommended while taking pregabalin
- Men trying to father children: Pregabalin may affect sperm characteristics in a small percentage of men; discuss with your doctor
- Heart failure (NYHA Class III or IV): Use with caution; limited safety data exist for this group
- Children: Use in children for seizures is specific to Lyrica (capsules and oral solution) for ages 1 month and older; pregabalin capsules are approved for seizures only in patients 17 and older
🚑If you take too much▾
Taking too much pregabalin can cause reduced consciousness, confusion, agitation, anxiety, seizures, and heart rhythm problems. Deaths have been reported — both with pregabalin alone and when combined with other CNS depressants. There is no specific antidote; treatment focuses on supportive care and monitoring. Call a Poison Control Center immediately (1-800-222-1222 in the US) or go to the emergency room. Pregabalin can be partially removed by hemodialysis if needed.
📡Pharmacodynamics — effects in the body▾
Pregabalin reduces the release of pain-signaling chemicals (pro-nociceptive neurotransmitters) from nerve cells in the spinal cord by binding to the alpha-2-delta subunit of calcium channels. This calms the overactive nerve signals that drive chronic nerve pain and may also reduce abnormal electrical activity that contributes to seizures. It does not block sodium channels, is not active at opioid receptors, and does not affect serotonin, dopamine, or noradrenaline reuptake — which distinguishes it from many other pain and mood medications.
🔬Pharmacokinetics — how your body processes it▾
Pregabalin is rapidly and reliably absorbed when taken by mouth, with more than 90% of the dose reaching the bloodstream regardless of dose size. When taken without food, it peaks in the blood within about 1.5 hours; food slows absorption but does not reduce the total amount absorbed. The body clears pregabalin almost entirely through the kidneys — about 90% is excreted unchanged in the urine — with a half-life of roughly 6 hours in people with normal kidney function. Because elimination is so closely tied to kidney function, people with kidney disease or older adults with age-related kidney decline will need dose adjustments; hemodialysis also removes about 50% of pregabalin from the body in 4 hours.
📦How to store it▾
Store at 20° to 25° C (68° to 77° F), excursions permitted between 15° to 30° C (59° to 86° F) .
📄 Written from Pregabalin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Pregabalin
95 supplements and herbal products have documented interactions with Pregabalin in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 7
- Moderate · 73
- Minor · 15
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Pregabalin — the kind of thing our pharmacy team would talk through with you at the counter.
What is pregabalin actually used for? ▾
Will pregabalin make me feel dizzy or drowsy? ▾
Can I just stop taking pregabalin if I want to quit? ▾
Is it safe to drink alcohol while taking pregabalin? ▾
What should I watch for that would mean I need to call a doctor or get emergency help? ▾
Is pregabalin safe to take during pregnancy or while breastfeeding? ▾
Is Pregabalin available over the counter? ▾
Is Pregabalin a controlled substance? ▾
When was Pregabalin first available? ▾
Who makes Pregabalin? ▾
💬 Answers drafted from Pregabalin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Pregabalin comes
Pregabalin is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Capsule
How this form is used
- Lyrica capsules are approved for neuropathic pain from diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and spinal cord injury pain
- Lyrica capsules are approved as add-on therapy for partial-onset seizures in patients 1 month of age and older
- Pregabalin capsules are approved for neuropathic pain from diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and spinal cord injury pain
- Pregabalin capsules are approved as add-on seizure therapy for patients 17 years of age and older
- Lyrica and pregabalin capsules may be taken with or without food
- Doses are typically divided two or three times daily depending on the condition being treated
- Do not stop taking capsules abruptly — taper gradually over at least one week as directed by your prescriber
- Dose adjustment is required for adults with reduced kidney function
Extended-release tablet
How this form is used
- Lyrica CR is approved to manage neuropathic pain associated with diabetic peripheral neuropathy
- Lyrica CR is approved to manage postherpetic neuralgia
- Pregabalin Extended Release tablets are approved for neuropathic pain from diabetic peripheral neuropathy and postherpetic neuralgia
- Lyrica CR and Pregabalin Extended Release tablets have NOT been shown to be effective for fibromyalgia or as seizure add-on therapy
- Lyrica CR and Pregabalin Extended Release tablets are taken once daily after an evening meal
- Swallow Lyrica CR and Pregabalin Extended Release tablets whole — do not split, crush, or chew them
- If you miss your evening dose, take it before bedtime with a snack; if you miss the bedtime dose, take it after a morning meal
- Do not stop extended-release tablets abruptly — taper gradually over at least one week
Oral solution
How this form is used
- Lyrica oral solution is approved for neuropathic pain from diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and spinal cord injury pain
- Lyrica oral solution is approved as add-on therapy for partial-onset seizures in patients 1 month of age and older
- Pregabalin oral solution is approved for neuropathic pain from diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and spinal cord injury pain
- Pregabalin oral solution is approved as add-on therapy for partial-onset seizures in patients 1 month of age and older
- Lyrica and pregabalin oral solution may be taken with or without food
- Doses are typically divided two or three times daily depending on the condition
- Do not stop the oral solution abruptly — taper gradually over at least one week
- Dose adjustment is required for adults with reduced kidney function
📊 Pregabalin across the U.S. market
How Pregabalin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (32) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Pregabalin is used
A general measure of how commonly Pregabalin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Pregabalin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Pregabalin prescribed? Of the 1,597 medications we measure, Pregabalin ranks #109 by Medicaid prescriptions — more than 93% of them.
Utilization by Pregabalin product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
pregabalin 150 MG Oral Capsule Most dispensed
Summed across the 19 of 283 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483440
pregabalin 75 MG Oral Capsule
Summed across the 21 of 313 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483450
pregabalin 100 MG Oral Capsule
Summed across the 21 of 277 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483438
pregabalin 50 MG Oral Capsule
Summed across the 19 of 281 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483448
pregabalin 200 MG Oral Capsule
Summed across the 16 of 186 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483446
pregabalin 300 MG Oral Capsule
Summed across the 16 of 186 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483444
pregabalin 25 MG Oral Capsule
Summed across the 19 of 187 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483442
pregabalin 225 MG Oral Capsule
Summed across the 12 of 162 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 577127
pregabalin 20 MG/ML Oral Solution
Summed across the 3 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 898715
24 HR pregabalin 165 MG Extended Release Oral Tablet
Summed across the 2 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1988974
24 HR pregabalin 330 MG Extended Release Oral Tablet
Summed across the 2 of 11 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1988977
24 HR pregabalin 82.5 MG Extended Release Oral Tablet
Summed across the 1 of 11 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1988980
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Pregabalin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 151 of 1,914 listed Pregabalin NDCs with Medicaid activity.
🔍 Compare Pregabalin products
A representative set of FDA-listed product records for Pregabalin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 25 mg | Oral | A-S Medication Solutions | ANDA | View NDC → |
| 75 mg | Oral | A-S Medication Solutions × 11 listings | ANDA | View NDC → |
| 100 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 200 mg | Oral | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| 25 mg | Oral | Actavis Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 50 mg | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 75 mg | Oral | Actavis Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | Actavis Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 150 mg | Oral | Actavis Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 200 mg | Oral | Actavis Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 225 mg | Oral | Actavis Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Actavis Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 50 mg | Oral | Advanced Rx of Tennessee, LLC × 3 listings | ANDA | View NDC → |
| 75 mg | Oral | Advanced Rx of Tennessee, LLC × 3 listings | ANDA | View NDC → |
| 150 mg | Oral | Advanced Rx of Tennessee, LLC | ANDA | View NDC → |
| 225 mg | Oral | Advanced Rx of Tennessee, LLC | ANDA | View NDC → |
| 25 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 2 listings | ANDA | View NDC → |
| 50 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 8 listings | ANDA | View NDC → |
| 75 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 8 listings | ANDA | View NDC → |
| 75 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC | NDA AUTHORIZED GENERIC | View NDC → |
| 100 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 7 listings | ANDA | View NDC → |
| 150 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 8 listings | ANDA | View NDC → |
| 200 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 8 listings | ANDA | View NDC → |
| 25 mg | Oral | Alembic Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 50 mg | Oral | Alembic Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 75 mg | Oral | Alembic Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 100 mg | Oral | Alembic Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 150 mg | Oral | Alembic Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 200 mg | Oral | Alembic Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 225 mg | Oral | Alembic Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 300 mg | Oral | Alembic Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 25 mg | Oral | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 50 mg | Oral | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 75 mg | Oral | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 150 mg | Oral | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 200 mg | Oral | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 225 mg | Oral | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Alembic Pharmaceuticals Limited × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 50 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 75 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 150 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Amneal Pharmaceuticals NY LLC × 6 listings | ANDA | View NDC → |
| 50 mg | Oral | Amneal Pharmaceuticals NY LLC × 6 listings | ANDA | View NDC → |
| 75 mg | Oral | Amneal Pharmaceuticals NY LLC × 6 listings | ANDA | View NDC → |
| 100 mg | Oral | Amneal Pharmaceuticals NY LLC × 6 listings | ANDA | View NDC → |
| 150 mg | Oral | Amneal Pharmaceuticals NY LLC × 6 listings | ANDA | View NDC → |
| 200 mg | Oral | Amneal Pharmaceuticals NY LLC × 6 listings | ANDA | View NDC → |
| 225 mg | Oral | Amneal Pharmaceuticals NY LLC × 6 listings | ANDA | View NDC → |
| 300 mg | Oral | Amneal Pharmaceuticals NY LLC × 6 listings | ANDA | View NDC → |
| 25 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 2 listings | ANDA | View NDC → |
| 50 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 4 listings | ANDA | View NDC → |
| 75 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC | ANDA | View NDC → |
| 100 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 4 listings | ANDA | View NDC → |
| 150 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC | ANDA | View NDC → |
| 200 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 2 listings | ANDA | View NDC → |
| 225 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 3 listings | ANDA | View NDC → |
| 300 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC | ANDA | View NDC → |
Showing 200 of 1,326 products — FDA National Drug Code Directory. See every product, package size and price: browse all 1,326 Pregabalin NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Pregabalin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Pregabalin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Pregabalin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 187832 3 dose forms · 13 strengths
-
Dose form (SCDF) Extended Release Oral Tablet RxCUI 1988973In current FDA listingsClinical drug / strength (SCD) 24 HR pregabalin 165 MGRxCUI 198897424 HR pregabalin 330 MGRxCUI 198897724 HR pregabalin 82.5 MGRxCUI 1988980 -
Dose form (SCDF) Oral Capsule RxCUI 483437In current FDA listings -
Dose form (SCDF) Oral Solution RxCUI 898714In current FDA listings
Look up RxCUI 187832 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Pregabalin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Pregabalin belongs to the Gabapentinoids class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 233 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Viatris Specialty LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.